Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.60 |
| ▸ | PNP | P00491 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.56 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | PIM1 | P11309 | 1/20 | 0.56 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.56 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.56 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.56 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13058825 | 1.00 | HIF1A (0.60) | HIF1APNPLMNATP53HTT | |
| SCHEMBL21423035 | 1.00 | HIF1A (0.60) | HIF1APNPLMNATP53HTT | |
| SCHEMBL14628598 | 1.00 | HIF1A (0.60) | HIF1APNPLMNATP53HTT | |
| SCHEMBL21263875 | 0.87 | TAS1R3 (0.48) | HIF1APNPLMNATP53HTT | |
| SCHEMBL24059955 | 0.84 | TAS1R3 (0.72) | — | |
| SCHEMBL20673218 | 0.84 | TAS1R3 (0.72) | — | |
| SCHEMBL20266264 | 0.84 | TAS1R3 (0.72) | — | |
| SCHEMBL20282807 | 0.84 | TAS1R3 (0.72) | — | |
| SCHEMBL20277518 | 0.84 | TAS1R3 (0.72) | — | |
| SCHEMBL14628596 | 0.81 | HIF1A (0.55) | HIF1APNPLMNATP53HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12270075-B2 | Tagged nucleoside compounds useful for nanopore detection | Roche Sequencing Solutions, Inc. (US) | 2025-04-08 | — | — | US | claimed |
| US-20250346950-A1 | TAGGED NUCLEOSIDE COMPOUNDS USEFUL FOR NANOPORE DETECTION | Roche Sequencing Solutions, Inc. (US) | 2025-11-13 | — | — | US | disclosed |
| EP-4562179-A1 | METHOD FOR THE ASSESSMENT OF THE PHOTOPROTECTIVE ACTIVITY OF A DEVICE | Pierre Fabre Dermo-Cosmétique (FR) | 2025-06-04 | — | — | EP | disclosed |
| US-12270075-B2 | Tagged nucleoside compounds useful for nanopore detection | Roche Sequencing Solutions, Inc. (US) | 2025-04-08 | — | — | US | disclosed |
| US-20240376538-A1 | PRETREATMENT METHOD FOR DNA ADDUCTOMICS SAMPLES | NATIONAL INSTITUTES OF HEALTH | 2024-11-14 | — | — | US | disclosed |
| US-12054768-B2 | Methods for detecting agglutination and compositions for use in practicing the same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-08-06 | — | — | US | disclosed |
| WO-2024023436-A1 | METHOD FOR THE ASSESSMENT OF THE PHOTOPROTECTIVE ACTIVITY OF A DEVICE | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2024-02-01 | — | — | WO | disclosed |
| US-20230159999-A1 | COMPOSITIONS THAT REDUCE TEMPLATE THREADING INTO A NANOPORE | Roche Sequencing Solutions, Inc. | 2023-05-25 | — | — | US | disclosed |
| EP-4123031-A1 | METHODS FOR DETECTING AGGLUTINATION AND COMPOSITIONS FOR USE IN PRACTICING THE SAME | The Regents of The University of California (US) | 2023-01-25 | — | — | EP | disclosed |
| EP-4100415-A1 | COMPOSITIONS THAT REDUCE TEMPLATE THREADING INTO A NANOPORE | F. Hoffmann-La Roche AG (CH) | 2022-12-14 | — | — | EP | disclosed |
| EP-3283638-B1 | METHODS FOR DETECTING AGGLUTINATION AND USE OF KITS IN PRACTICING THE SAME | UNIV CALIFORNIA (US) | 2022-06-08 | — | — | EP | disclosed |
| US-20210403978-A1 | METHODS FOR DETECTING AGGLUTINATION AND COMPOSITIONS FOR USE IN PRACTICING THE SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2021-12-30 | — | — | US | disclosed |
| US-11149296-B2 | Methods for detecting agglutination and compositions for use in practicing the same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-10-19 | — | — | US | disclosed |
| EP-3739065-A1 | SOMATIC MUTATION-BASED CLASSIFICATION OF CANCERS | Fundació Centre de Regulació Genòmica (ES) | 2020-11-18 | — | — | EP | disclosed |
| US-20200232005-A1 | Methods of Producing and Using Single-Stranded Deoxyribonucleic Acids and Compositions for Use in Practicing the Same | TAKARA BIO USA, INC. | 2020-07-23 | — | — | US | disclosed |
| US-10584363-B2 | Methods of producing and using single-stranded deoxyribonucleic acids and compositions for use in practicing the same | TAKARA BIO USA, INC. (US) | 2020-03-10 | — | — | US | disclosed |
| US-20180100181-A1 | METHODS FOR DETECTING AGGLUTINATION AND COMPOSITIONS FOR USE IN PRACTICING THE SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-04-12 | — | — | US | disclosed |
| US-20170349927-A1 | METHODS OF PRODUCING AND USING SINGLE-STRANDED DEOXYRIBONUCLEIC ACIDS AND COMPOSITIONS FOR USE IN PRACTICING THE SAME | TAKARA BIO USA, INC. | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346950-A1 | TAGGED NUCLEOSIDE COMPOUNDS USEFUL FOR NANOPORE DETECTION | PNP, NT5C3B, POLN | HIF1A 4747/4885PNP 1/4885LMNA 576/4885 |
| US-12270075-B2 | Tagged nucleoside compounds useful for nanopore detection | NT5C3B, PNP, POLN | HIF1A 4689/4885PNP 2/4885LMNA 608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.